SUBMISSION DEADLINE: SEPTEMBER 3, 2024

All accepted papers will be limited to 5-minute presentations. Within each session, there will be time for panel discussion. All paper abstract submissions will be peer-reviewed by the ASCRS Program Committee and appropriate Clinical Committees. Abstracts will be graded on content and scientific integrity. Submissions by non-MDs/DOs will be reviewed in the context of the presenter’s training and education.

NUMBER OF SUBMISSIONS PER PERSON

Submissions are limited to 3 abstracts per person.

RESPONSIBILITIES OF THE LEAD AUTHOR

• Prior to submitting, the lead author must complete their Financial Interest Disclosure and ASCRS Faculty CME Review.
• Lead authors must notify coauthors to enter their Financial Interest Disclosure and ASCRS Faculty CME Review by February 13, 2025. Authors who do not complete the process cannot be included in the abstract.

ABSTRACT STRUCTURE

Please read the following instructions carefully before completing the submission:

Title (limited to 140characters, including spaces and punctuation)

For CME purposes, product/trade names cannot be used in the title. Generic descriptors are required. Titles with product/trade names may be rejected. The title should not be formulated as a question or statement (i.e., should not include a verb). Titles should follow title case rules and may be edited by ASCRS editorial staff. Please use title case when completing the submission. The title should accurately and concisely reflect the submission content.

Category

Choose from the categories and topics available on site.

Purpose (Limited to 350 characters, including spaces and punctuation)

Indicate the question that the study answers or the hypothesis it tests. Do not include names or affiliations of authors. Do not include sponsorships, grants, etc.

Methods (Limited to 700 characters, including spaces and punctuation)

Describe the study design, indicating randomization, masking, and whether the data collection was retrospective or prospective, if applicable. Identify the patients, including selection procedures, inclusion criteria, and numbers. Indicate the intervention procedures and the outcome measures.

Results (Limited to 700 characters, including spaces and punctuation)

Present the outcomes and measurements. Data should include the level of statistical significance.

Conclusion (Limited to 350 characters including spaces and punctuation)

State the conclusion and clinical pertinence.

 

SUBMISSION DEADLINE: SEPTEMBER 3, 2024

ELECTRONIC POSTERS DUE FOR JUDGING: FEBRUARY 18, 2025

ALL ELECTRONIC POSTER DUE: APRIL 2, 2025

All accepted and uploaded electronic posters will be available for viewing on demand in the Poster Pavilion at the Convention Center during the meeting and available for viewing on the ASCRS website post-meeting. Questions from attendees will be submitted electronically to the lead author’s email. All poster abstract submissions will be peer-reviewed by the ASCRS Program Committee, poster judges, and appropriate Clinical Committees. Abstracts will be graded on content and scientific integrity. Submissions by non-MDs/DOs will be reviewed in the context of the presenter’s training and education. The Poster Judging Committee will select winning Posters from 4 categories: Cataract, Cornea, Glaucoma and Keratorefractive.

NUMBER OF SUBMISSIONS PER PERSON

Submissions are limited to 3 abstracts per person.

RESPONSIBILITIES OF THE LEAD AUTHOR

• Prior to submitting, the lead author must complete their Financial Interest Disclosure and ASCRS Faculty CME Review.
• Lead authors must notify coauthors to submit their Financial Interest Disclosure. Those who have not submitted by February 13 cannot be included on the abstract.
• In submitting a poster, the lead author attests that he/she has reviewed each coauthor’s financial interests and determined there is no conflict of interest.
• Lead author must register for the Annual Meeting.

ABSTRACT STRUCTURE

Please read the following instructions carefully before completing the submission:

Title (Limited to 140 characters including spaces and punctuation)

For CME purposes, product/trade names cannot be used in the title. Generic descriptors are required. Titles with product/trade names may be rejected. The title should not be formulated as a question or statement (i.e., should not include a verb). Titles should follow title case rules and may be edited by ASCRS editorial staff. The title should accurately and concisely reflect the submission content.

Category

Choose from the categories and topicsavailable on the site.

Purpose (Limited to 350 characters, including spaces and punctuation)

Indicate the question that the study answers or the hypothesis it tests. Do not include names or affiliations of authors. Do not include sponsorships, grants, etc.

Methods (Limited to 700 characters, including spaces and punctuation)

Describe the study design, indicating randomization, masking, and whether the data collection was retrospective or prospective, if applicable. Identify the patients, including selection procedures, inclusion criteria, and numbers. Indicate the intervention procedures and outcome measures.

Results (Limited to 700 characters, including space and punctuation)

Present the outcomes and measurements. Data should include the level of statistical significance.

Conclusion (Limited to 350 characters, including space and punctuation)

State the conclusion and clinical pertinence.

LIVE POSTER PRESENTATIONS

Electronic posters selected for an award will be given the opportunity to present their poster live at the meeting in a session moderated by the poster judges. Presentation time/date to be announced by early March 2025. Details on more presentation opportunities to come!

 

For more information, please see the 2025 ASCRS Submission Guide 提交指南

To begin a submission, please click here 点此提交

The 43rd ASCRS Film Festival will be held during the 2025 ASCRS Annual Meeting. Winning films are showcased at the ASCRS Annual Meeting during the Film Festival Ceremony. Submitted films are judged, and awards are given to the top films in each category with an overall grand prize winner. In addition, all submitted films are available to view in the ASCRS Education Hub during the ASCRS Annual Meeting and on the ASCRS website, year-round. Award-winning films are also celebrated for their innovation and educational value throughout the year in ASCRS publications, ASCRS social networking sites, ASCRS' CME 24/7 platform, and at other important ophthalmology meetings around the world.

Contact information for films: Lindsay Kunz lkunz@ascrs.org

KEY DATES FOR FILM SUBMISSIONS:

• August 26: Title and synopsis deadline
• December 6: Submission acceptance notification with edited titles emailed to producer
• January 7 – February 18, 2025: Deadline for film uploads
• April 27, 2025: Film Festival Awards Reception and Ceremony

PEER REVIEW AND ACCEPTANCE OF SUBMISSION

• Film submission synopses will be peer-reviewed by the ASCRS Program Committee and appropriate Clinical Committee for content and scientific integrity
• Accepted films will be scored by a panel of judges
• Submissions by non-MDs will be reviewed in the context of the presenter’s training and education

NUMBER OF FILM SUBMISSIONS ALLOWED PER PERSON

• 1 as first producer
• 2 additional film submissions as co-producer, for a total of 3 film submissions

PRESENTATION OF FILM

• Film producers must be registered for and attend the 2025 ASCRS Annual Meeting and must attend the ASCRS Film Festival Awards Ceremony to be eligible for final film judging and awards. Registration and proof of badge pickup will be referenced.
• Special circumstances may arise; the producer must send a substitute in their place that is not a member of industry; the substitute will accept, on stage, any award/s that may be given to the film producer
• Send the name of the substitute to Film Festival Program Manager Lindsay Kunz, lkunz@ascrs.org

INSTRUCTIONS IN ORDER OF COMPLETION

Responsibilities of the Lead Producer

• Complete their Financial Interest Disclosure and ASCRS Faculty CME Review.
• To add co-producers, notify them to create an account at https://ascrs.confex.com/ascrs/ficme25/cfp.cgi and submit their Financial Interest Disclosure.
• Co-producers who have not submitted their financial interest disclosure will not be included in the Final Program.
• Your submission will not be reviewed for acceptance until you have completed all the steps.

Film Submission Categories

• Cataract Complications
• Cataract/Implant Surgery
• Glaucoma Surgery
• In-House Productions: A video produced by the author independent of financial or technical resources provided by a professional entity.
• Instruments and Devices/IOLs
• New Producer/Young Physician: Combined category that includes the New Producer of any age and the Young Physician. New Producers can submit in this category if this is their 1st or 2nd film as the lead producer and they have not won in a society Film Festival as the lead producer. A Young Physician producer is in their first 5 years of practice and has not won in a society film festival as the lead producer.
• New Techniques
• Quality Teaching
• Refractive/Cornea Surgery
• Special Interest: Videos that don’t easily fit into the other categories because of their unusual subject matter or unique approach.

Title and Synopsis

• The title should accurately and concisely reflect the submission content
• Product/trade names should not be used in the title and will be edited out; generic descriptors are required
• The title should not be formulated as a question or statement (i.e., should not include a verb)
• Title should follow title case rules and may be edited by ASCRS editorial staff (do not enter the title in all caps)
• Title limit: 140 characters, including spaces and punctuation
• Synopsis: The synopsis should provide a brief overview of your film (Synopsis limit: 400 characters, including spaces and punctuation)

 

For more information and film specifications, please see the 2025 ASCRS Submission Guide 提交指南

To begin a submission, please click here 点此提交